Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0

Ashish M. Kamat; Joaquim Bellmunt; Matthew D. Galsky; Badrinath R. Konety; Donald L. Lamm; David Langham; Cheryl T. Lee; Matthew I. Milowsky; Michael A. O'Donnell; Peter H. O'Donnell; Daniel P. Petrylak; Padmanee Sharma; Eila C. Skinner; Guru Sonpavde; John A. Taylor; Prasanth Abraham; Jonathan E. Rosenberg

doi:10.1186/s40425-017-0280-z

Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0

Ashish M. Kamat
, Joaquim Bellmunt
, Matthew D. Galsky
, Badrinath R. Konety
, Donald L. Lamm
, David Langham
, Cheryl T. Lee
, Matthew I. Milowsky
, Michael A. O'Donnell
, Peter H. O'Donnell
, Daniel P. Petrylak
, Padmanee Sharma
, Eila C. Skinner
, Guru Sonpavde
, John A. Taylor
, Prasanth Abraham
, Jonathan E. Rosenberg

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Abstract

After the publication of the article [1], the treatment algorithm for advanced/metastatic bladder cancer in Fig. 3 was updated to reflect the current use of immunotherapy in this setting. The correct Fig. 3 can be seen here and the original article has been updated to reflect this change.

Original language	English
Article number	80
Journal	Journal for ImmunoTherapy of Cancer
Volume	5
Issue number	1
DOIs	https://doi.org/10.1186/s40425-017-0280-z
State	Published - 28 Sep 2017

Access to Document

10.1186/s40425-017-0280-z

Fingerprint

Dive into the research topics of 'Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0'. Together they form a unique fingerprint.

Cite this

Kamat, A. M., Bellmunt, J., Galsky, M. D., Konety, B. R., Lamm, D. L., Langham, D., Lee, C. T., Milowsky, M. I., O'Donnell, M. A., O'Donnell, P. H., Petrylak, D. P., Sharma, P., Skinner, E. C., Sonpavde, G., Taylor, J. A., Abraham, P., & Rosenberg, J. E. (2017). Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0. Journal for ImmunoTherapy of Cancer, 5(1), Article 80. https://doi.org/10.1186/s40425-017-0280-z

@article{bb29069b82444e5a913e0f4a7243082c,

title = "Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0",

abstract = "After the publication of the article [1], the treatment algorithm for advanced/metastatic bladder cancer in Fig. 3 was updated to reflect the current use of immunotherapy in this setting. The correct Fig. 3 can be seen here and the original article has been updated to reflect this change.",

author = "Kamat, \{Ashish M.\} and Joaquim Bellmunt and Galsky, \{Matthew D.\} and Konety, \{Badrinath R.\} and Lamm, \{Donald L.\} and David Langham and Lee, \{Cheryl T.\} and Milowsky, \{Matthew I.\} and O'Donnell, \{Michael A.\} and O'Donnell, \{Peter H.\} and Petrylak, \{Daniel P.\} and Padmanee Sharma and Skinner, \{Eila C.\} and Guru Sonpavde and Taylor, \{John A.\} and Prasanth Abraham and Rosenberg, \{Jonathan E.\}",

note = "Publisher Copyright: {\textcopyright} 2017 The Author(s).",

year = "2017",

month = sep,

day = "28",

doi = "10.1186/s40425-017-0280-z",

language = "English",

volume = "5",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BMJ Publishing Group",

number = "1",

}

Kamat, AM, Bellmunt, J, Galsky, MD, Konety, BR, Lamm, DL, Langham, D, Lee, CT, Milowsky, MI, O'Donnell, MA, O'Donnell, PH, Petrylak, DP, Sharma, P, Skinner, EC, Sonpavde, G, Taylor, JA, Abraham, P & Rosenberg, JE 2017, 'Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0', Journal for ImmunoTherapy of Cancer, vol. 5, no. 1, 80. https://doi.org/10.1186/s40425-017-0280-z

Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0. / Kamat, Ashish M.; Bellmunt, Joaquim; Galsky, Matthew D. et al.
In: Journal for ImmunoTherapy of Cancer, Vol. 5, No. 1, 80, 28.09.2017.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0

AU - Kamat, Ashish M.

AU - Bellmunt, Joaquim

AU - Galsky, Matthew D.

AU - Konety, Badrinath R.

AU - Lamm, Donald L.

AU - Langham, David

AU - Lee, Cheryl T.

AU - Milowsky, Matthew I.

AU - O'Donnell, Michael A.

AU - O'Donnell, Peter H.

AU - Petrylak, Daniel P.

AU - Sharma, Padmanee

AU - Skinner, Eila C.

AU - Sonpavde, Guru

AU - Taylor, John A.

AU - Abraham, Prasanth

AU - Rosenberg, Jonathan E.

PY - 2017/9/28

Y1 - 2017/9/28

N2 - After the publication of the article [1], the treatment algorithm for advanced/metastatic bladder cancer in Fig. 3 was updated to reflect the current use of immunotherapy in this setting. The correct Fig. 3 can be seen here and the original article has been updated to reflect this change.

AB - After the publication of the article [1], the treatment algorithm for advanced/metastatic bladder cancer in Fig. 3 was updated to reflect the current use of immunotherapy in this setting. The correct Fig. 3 can be seen here and the original article has been updated to reflect this change.

UR - https://www.scopus.com/pages/publications/85030264476

U2 - 10.1186/s40425-017-0280-z

DO - 10.1186/s40425-017-0280-z

M3 - Comment/debate

C2 - 28962591

AN - SCOPUS:85030264476

SN - 2051-1426

VL - 5

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

IS - 1

M1 - 80

ER -